[1] Sucky FJ,Sokol RJ,Balistreri WF.Liver disease in children.2nd ed.Philadelphia:Lippincott Williams&Wilkins,2001:565-594. [2] 顾学范,江载芳,申昆玲,等褚福堂实用儿科学.8版.北京:人民卫生出版社,2015:2263. [3] Oldfors A,Dimauro S. New insights in the field of muscle glycogenoses.Curr Opin Neurol,2013,26:544-553. [4] 胡亚美,江载芳,主编.诸福棠.实用儿科学.第7版.北京:人民卫生出版社,2002:2125-2132. [5] 张婷,朱启镕,68例小儿肝穿刺临床总结.中国临床医学,2001,8:570-572. [6] 张鸿飞,杨晓晋,朱世殊.1020例小儿肝穿刺组织病理学与临床的研究.中华儿科杂志,2002,40:131-134. [7] 陈小宁,牛焕红,晏伟,等.14例糖原累积病临床、病理特征及治疗.发育医学电子杂志,2014,2:224-227. [8] 曾召琼,易帆,谢小兵,糖原累积病研究进展.检验医学与临床,2018,15:3458-3461. [9] 黄巧燕,伊文霞,符娜,等.以意识障或惊厥为首发症状的儿童低血糖症临床特点和误诊分析.中国医刊,2013,48:22-24. [10] 王小军,张改秀,宋文惠,等.难治性小儿低血糖症20例临床分析.中国药物与临床,2018,18:944-946. [11] 刘强,郑敏,糖原累积症患儿的临床特点分析中国优生与遗传杂志,2013,21:122-123. [12] Mason HH,Anderson DH.Glycogen disease of the liver(von Gierke's disease)with hepatomata:case report with metabolic studies.Pediatrics,1955,16:785-800. [13] 唐晓艳,陈萌,马明圣,等.82例糖原累积症Ⅰa型肝脏受累特点.协和医学杂志,2014,5:405-407. [14] Kishnani PS,Chuang TP,Bali D,et al.Chromosomal and genetic alterations in human hepatocellular adenomas associatde with typeⅠa glycogen storage disease.Hum Mol Genet,2009,18:4781-4190. [15] Rajas F,Clar J,Cautierstein A,et al.Lessons fron new mouse models of glycogen storage disease type Ⅰa in relation to the time course and organ specificity of the disease.J Inherit Dis,2015,38:521. [16] van Aalten SM,Witjes CD,de Man RA,et al.Can a decision-making model be justified in the management of hepatocellular adenoma.Liver Int,2012,32:28-37. [17] 夏晓刚,王凡,陈嘉佳,等.手术治疗合并肝脏多发腺瘤的Ⅰa型糖原累积症1例.中华普通外科学文献(电子版),2018,12:128-129. [18] 熊倩倩,漆学良,糖原累积病的诊断疗进展.中风与神经疾病杂志,2017,34:957-960. [19] Moses S W,Parvari R.The variable presentation of glycogen storage disease type Ⅳ:a review of clinical.enzymatic and molecular Studies.Curr Mol Med,2002,2:177-188. [20] 王丽晏,张鸿飞,董漪,等.糖原累积病Ⅳ型二例的临床与肝脏病理特点及文献复习.中国优生与遗传杂志,2012,20:131-135. |